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Dysfunction of the CFTR protein results in viscous mucus in the nose and paranasal
sinuses, with consequent bacterial overgrowth and infection. In patients with Cystic
Fibrosis sinonasal pathology may decrease quality of life and the sinuses can be a
bacterial reservoir from which cross-infection to the lungs may occur.
Objectives: Investigation of the impact of sinonasal pathology in adult patients
with Cystic Fibrosis.
Methods: In 90 adult patients with CF the following procedures were performed: a
quality of life questionnaire (RSOM-31); examination of nose, ear and throat; nasal
and sputum cultures and computed tomography of the paranasal sinuses.
Results: The results of 90 patients display nasal polyps in 27.8%. In 47.8% of the
subjects the nasal cultures and the sputum cultures show similarity in phenotype. In
many CF patients at least one of the sphenoidal or frontal sinuses was aplastic or
hypoplastic. The anatomy of the ostiomeatal complex was abnormal in 53 patients,
32.1% of them reported no sinus surgery in the past. Despite these ﬁndings, patients
report a minimal impact of sinonasal pathology on their quality of life.
Conclusions: In conclusion the prevalence of sinonasal pathology in adult patients
with CF is considerable. Nasal polyps are more prevalent than in the healthy
population and micro-organisms of the nose are often similar to those of the lungs.
The anatomy of the sinonasal system differs considerably from patients without CF;
CT-scans display smaller or aplastic sphenoidal and frontal sinuses and an abnormal
anatomy of the ostiomeatal complex.
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Background: CF sinuses are often colonised with bacteria that are pathogenic for
the lungs. They develop into different phenotypes in the sinuses, and the virulent and
resistant phenotypes can maintain the deleterious lung infections being a part of the
united airways. Though the evidence is sparse, theoretically, eradication of the sinus
bacteria can reduce the frequencies of lung colonisations. Nevertheless, whether
bacteria in the CF sinuses are eligible for eradication has never been addressed.
Material and Methods: A prospective study of 60 CF patients who had extensive
sinus surgery and had growth of Pseudomonas aeruginosa, Achromobacter xylosox-
idans and/or Burkholderia multivorans in their sinuses were initiated. The patients
followed a systematic postoperative treatment program with nasal irrigations with
saline and Colistimethate sodium and were endoscopically cleansed. All patients
had thorough follow-up examinations including sinus cultures. Each side of the
nose was cultured separately.
Results: At the six months follow-up, only 30 sinuses showed re-growth of
pathogenic bacteria of the original 104 sides with pathogenic bacterial growth at
surgery. Some of the patients were intermittently sinus colonized. However, 49
sinuses had no re-growth at any time during six months of follow-up. The patient
with the longest follow-up had no re-growth for three years.
Conclusion: CF sinuses can be eradicated of pathogenic bacteria.
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Intranasal nebulisation seems to be the best therapeutic option for local antibiotic
delivery, targeting infected sites beyond the nasal valve, especially for CF patients
whose maxillary sinuses (MS) may be a source for bacterial inducing lung infections.
In this study, we have evaluated the NL11SN sonic nebuliser (100Hz) on MS ventilation
and on aerosol deposition, in an in vitro model and in normal volunteers.
Scintigraphy of 81mKr gas ventilation and of 99mTc-DTPA sonic aerosol deposition
with NL11SN (DTF, France) was performed in 7 subjects. MS deposition was quan-
tiﬁed using an image processing method. In vitro nebulisations were performed in a
plastinated head model either with 99mTc-DTPA or with gentamicin. 99mTc-DTPA
deposited in the MS was quantiﬁed by image processing method and gentamicin by a
ﬂuorescence polarization immunoassay.
Ventilation 81mKr images show that the 100Hz sound increases MS gas ventilation.
99mTc-DTPA nebulised in volunteers was mainly deposited into nasal cavities (2/3 vs.
1/3 in lungs) with 4.9±2.5% of total nasal deposition in the MS. In the plastinated
head model, sonic mode of NL11SN increased the gentamicin deposition in MS by a
factor 3 (P < 0.05). The 99mTc-DTPA nebulised in the head model was deposited as
44.2±2.0% in the nasal cavities, with 4.6±2.6% into the MS (in term of total nasal
deposition).
The NL11SN sonic nebuliser can be used efﬁciently with antibiotics to target the nasal
cavities including maxillary sinuses, a major site of bacterial infections. Compared to
pulmonary deposition, the amount of sinus drug deposition per unit of tissue surface
seems sufﬁcient to induce a local therapeutic effect.
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Introduction: Air pollution is linked to adverse cardiopulmonary effects, especially
in chronic disease. Goss et al. showed that annual average rates of air pollution were
associated with lung function decrease and increased risk of CF exacerbation [1]
but acute changes so far have not been studied.
Aim: We investigated whether CF exacerbations were triggered by increases in air
pollution.
Methods: 215 CF patients were analyzed in a case-crossover analysis. Exacerba-
tions deﬁned as the need for additional antibiotic (AB) treatment, were registered.
In a time stratiﬁed case-crossover analysis, timing of exacerbation in CF patients
was related to the degree of air pollution (particulate matter, ozone and NO2). We
matched control days on temperature to exclude confounding by variations in daily
temperature and we controlled for day of the week. We used data gathered between
1 January 1998 and 31 December 2010.
Results:We evaluated 215 patients (male 49%, mean age 21 years ±13). They had a
total of 2204 antibiotic treatment periods (1107 intravenous and 1097 oral). A higher
PM10, ozone and NO2 concentration on the day of the AB event was associated with
increased likelihood of receiving AB treatment (OR= 1.048, p = 0.009 for PM10;
OR= 1.033, p = 0.023 for ozone; and OR= 1.116, p< 0.001 for NO2). A 10mg/m3
increase of NO2 1 day before the event was associated with 1.063 times higher
odds (p = 0.016) for having an exacerbation.
Conclusion: Acute changes in air pollution may trigger exacerbation in CF patients.
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